Hormonal IUDs Linked to Increased Breast Cancer Risk
During follow-up of almost 7 years, hormone-releasing IUD use conferred a 40% higher risk of breast cancer. The data showed a trend toward increasing risk with duration of IUD use, reaching 80% among women who reported using the devices for 10-15 years.
Contraceptive coil may be linked to increased risk of breast cancer, study shows
The study found an 'unexpected' association between the use of an intrauterine system, also known as an hormonal coil, and an increased risk of the cancer in women aged 15 to 49
Breast Cancer Awareness Month: The Link Between IUD And Breast Cancer
A Danish study published in JAMA reveals a potential link between levonorgestrel-releasing IUDs and breast cancer risk, with higher risks tied to longer usage durations.
Some IUDs linked to higher rates of breast cancer, but overall risk remains low
A new study adds to a growing set of evidence that women who use hormonal birth control have higher rates of breast cancer, but experts have stressed that the overall risk remains low.
Hormonal IUDs increase risk of breast cancer nearly the same as hormonal pills, study finds
Women who use a hormone-releasing intrauterine device, or IUD, face around the same risk of breast cancer as women who take hormonal birth control pills, according to a new study. The study, published Wednesday in JAMA Network,
Breast cancer risk linked with hormone-releasing IUD, study finds
Women who used hormone-releasing IUDs were found to have a 40% higher chance of developing breast cancer compared to those who didn’t use hormonal contraceptives, according to a JAMA study.
MassDevice2d
Hologic to acquire Gynesonics in $350M deal
Hologic this week announced it signed a definitive agreement to acquire Gynesonics for approximately $350 million.
Intrauterine Devices Market Predicted To Grow At 3.5% CAGR, Reaching $8.67 Billion By 2032
Intrauterine Devices Market Growing consciousness of long-acting reversible contraceptives (LARC) is driving the <a target=_blank href ...
3 Things You May Not Know About Birth Control After Pregnancy
In the haze of postpartum and caring for a newborn, remembering to stay on top of your birth control can be overwhelming. An ...
Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments
On Monday, Hologic Inc (NASDAQ:HOLX) agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a ...
WBJournal2d
Hologic to purchase California women’s health device manufacturer for $350M
Medical device manufacturer Hologic is broadening its focus on women’s health as the Marlborough-based firm has signed a ...
WebMD6d
Mirena 21 Mcg/24 Hr (Up To 8 Years) 52 Mg Intrauterine Device - Uses, Side Effects, and More
If you have any questions, ask your doctor or pharmacist. This device is placed in your uterus by a health care provider during an in-office visit. It is left in place for up to 8 years.
Democrats call on Pa. Senate leaders to pass bill to expand and protect contraception access
Democratic lawmakers called on Senate Republicans to pass a bill that would protect and expand access to contraception in ...
Morningstar22d
3Daughters Announces NIH to Support Testing of Novel Frameless Magnetic Copper IUD (3D-001) for Contraception
The first product, (3D-001), is a frameless, magnetic, non-hormonal intrauterine device (IUD) for long-acting contraception that conforms to a woman’s body. Combined with our unique, patented ...
Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health
Gynesonics pioneered and launched the Sonata System, the first FDA-cleared medical device for diagnostic intrauterine imaging ...